KIORA PHARMACEUTICALS Trademark

Trademark Overview


On Tuesday, November 2, 2021, a trademark application was filed for KIORA PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the KIORA PHARMACEUTICALS trademark a serial number of 97104601. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Wednesday, November 13, 2024. This trademark is owned by Eyegate Pharmaceuticals, Inc.. The KIORA PHARMACEUTICALS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, substances, active principles in the nature of therapeutic agents in the form of liquids, solutions, suspensions, injectables, eyedrops, tablets, powders, and capsules that provide the active ingredients for a wide variety of pharmaceuticals, and pharmaceutical compounds all for the treatment of inflammation, immune diseases and disorders, nervous system diseases and disorders, and ophthalmic diseases and disorders; ophthalmic preparations; oral medications in the nature of oral pharmaceuticals and therapeutics all for the treatment of ophthalmic diseases and disorders
kiora pharmaceuticals

General Information


Serial Number97104601
Word MarkKIORA PHARMACEUTICALS
Filing DateTuesday, November 2, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateWednesday, November 13, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 20, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations, substances, active principles in the nature of therapeutic agents in the form of liquids, solutions, suspensions, injectables, eyedrops, tablets, powders, and capsules that provide the active ingredients for a wide variety of pharmaceuticals, and pharmaceutical compounds all for the treatment of inflammation, immune diseases and disorders, nervous system diseases and disorders, and ophthalmic diseases and disorders; ophthalmic preparations; oral medications in the nature of oral pharmaceuticals and therapeutics all for the treatment of ophthalmic diseases and disorders
NOT AVAILABLE"PHARMACEUTICALS"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 17, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameKIORA PHARMACEUTICALS, INC.
Party Type22 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressEncinitas, CA 92024

Party NameKiora Pharmaceuticals, Inc.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressSalt Lake City, UT 84105

Party NameEyegate Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWaltham, MA 92452

Party NameEyegate Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWaltham, MA 92452

Trademark Events


Event DateEvent Description
Wednesday, August 17, 2022EXAMINERS AMENDMENT -WRITTEN
Friday, November 5, 2021NEW APPLICATION ENTERED
Friday, November 12, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 11, 2022ASSIGNED TO EXAMINER
Wednesday, August 17, 2022EXAMINERS AMENDMENT E-MAILED
Wednesday, August 17, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, August 17, 2022EXAMINER'S AMENDMENT ENTERED
Wednesday, August 17, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 31, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 20, 2022PUBLISHED FOR OPPOSITION
Tuesday, September 20, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, September 23, 2022TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, October 11, 2022ASSIGNED TO PETITION STAFF
Friday, October 21, 2022CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Tuesday, November 15, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, October 26, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, May 15, 2023SOU TEAS EXTENSION RECEIVED
Monday, May 15, 2023SOU EXTENSION 1 FILED
Monday, May 15, 2023SOU EXTENSION 1 GRANTED
Wednesday, May 17, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 14, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, November 14, 2023SOU EXTENSION 2 FILED
Tuesday, November 14, 2023SOU EXTENSION 2 GRANTED
Thursday, November 16, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 13, 2024SOU EXTENSION 3 GRANTED
Monday, May 13, 2024SOU EXTENSION 3 FILED
Monday, May 13, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, May 14, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 8, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, November 8, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, November 8, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, November 8, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, November 8, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 13, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, November 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 13, 2024SOU EXTENSION 4 GRANTED
Wednesday, November 13, 2024SOU EXTENSION 4 FILED